🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Clinical Trials in Turkey / NCT06957470
Active, not recruiting Observational

TCI vs. Manuel TIVA in Septorhinoplasty Surgeries

NCT06957470 · tracked via the Priya Life Science Turkey tracker
Sponsor
Bulent Ecevit University
Phase
Observational
Started
2025-04-01
Last updated
2025-05-04

Condition(s) studied

Anesthesia

Investigational drug(s) / intervention(s)

Total Intravenous Anesthesia

Total Intravenous Anesthesia: It is a general anesthesia technique performed through a combination of intravenous agents administered intravenously by various methods.

Study summary

Septorhinoplasty is a surgical technique that can be used to correct various nasal deformities.Total intravenous anesthesia (TIVA) is a frequently preferred method as an anesthesia technique in septorhinoplasty surgeries.It has been reported that TIVA reduces the incidence of postoperative nausea and vomiting, is more successful in acute postoperative pain control compared to inhalational anesthesia, provides more stable hemodynamics, provides quicker awakening after anesthesia, is more effective in preventing recovery agitation and cough, and is effective in controlled hypotension.

Eligibility

Sex
ALL
Min age
18 Years
Max age
65 Years
Healthy volunteers
Accepted
Inclusion Criteria: * Patients aged 18-65 years with American Society of Anesthesiology (ASA) physical status I-II who will undergo Septorhinoplasty Surgery under general anesthesia will be included in the study. Exclusion Criteria: Patients who do not agree to participate in the study Patients under 18 and over 65 Patients with ASA score III and above Clinical diagnosis of neuropsychiatric disorders Those with a history of chronic NSAID, tranquilizer, opioid or sleeping pill use Clinical diagnosis of Serious cardiac diseases Clinical diagnosis of central-autonomic nervous system disease Clinical diagnosis of Coagulopathy Those with soybean oil allergy and a history of allergy to any study drug BMI \>30 kg m2, pregnancy breastfeeding patients

Primary outcome measure(s)

Trial sites (2)

FacilityCityRegionStatus
Zonguladk Bulent ecevit University Zonguldak Kozlu
Bulent Ecevit University Zonguldak Zonguldak Province

More Bulent Ecevit University trials in Turkey

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06957470 on ClinicalTrials.gov ↗ ← All trials in Turkey